Kistler-Tiffany Companies’s Sarepta Therapeutics SRPT Stock Holding History

Kistler-Tiffany Companies’s Portfolio SRPT Stock Details SRPT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$105K	Hold
2023 Q1	$127K	Sell
2022 Q4	$131K	Hold
2022 Q3	$112K	Hold
2022 Q2	$76K	Buy
2022 Q1	$73K	Buy
2021 Q4	$80K	Buy
2021 Q3	$72K	Buy
2021 Q2	$32K	Buy